Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial.
<h4>Background</h4> <p>Human immunodeficiency virus (HIV)-related chronic lung disease (CLD) among children is associated with substantial morbidity, despite antiretroviral therapy. This may be a consequence of repeated respiratory tract infections and/or dysregulated immune activ...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2017
|